Michael W Weiner

Author PubWeight™ 417.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010 19.42
2 The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 2008 14.68
3 Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013 9.43
4 Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 2005 7.90
5 The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am 2005 7.26
6 Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 2004 7.07
7 A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement 2008 6.39
8 Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol 2015 5.10
9 Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain 2010 4.39
10 Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 2009 3.97
11 Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage 2006 3.85
12 Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 2012 3.73
13 Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage 2008 3.40
14 Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia. J Magn Reson Imaging 2002 3.34
15 Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage 2010 3.27
16 Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005 3.14
17 Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement 2010 3.11
18 Neuroanatomical correlates of behavioural disorders in dementia. Brain 2005 2.92
19 Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement 2010 2.88
20 The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis Assoc Disord 2006 2.86
21 Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol 2012 2.84
22 Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol 2011 2.83
23 Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage 2009 2.80
24 Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement 2010 2.79
25 Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain 2007 2.72
26 Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol 2008 2.71
27 Voxelwise genome-wide association study (vGWAS). Neuroimage 2010 2.69
28 Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement 2010 2.68
29 Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol 2006 2.62
30 Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain 2009 2.61
31 Longitudinal change of biomarkers in cognitive decline. Arch Neurol 2011 2.51
32 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage 2008 2.40
33 Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage 2008 2.30
34 Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. Neuroimage 2010 2.29
35 Structural anatomy of empathy in neurodegenerative disease. Brain 2006 2.28
36 Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. Neuroimage 2009 2.28
37 Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp 2009 2.28
38 Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 2006 2.27
39 Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA 2010 2.25
40 Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage 2008 2.25
41 Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging 2010 2.13
42 A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A 2010 2.12
43 White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain 2009 2.08
44 Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields. Hippocampus 2009 2.08
45 Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging 2010 2.05
46 Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol 2005 2.05
47 Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage 2009 2.03
48 Nearly automatic segmentation of hippocampal subfields in in vivo focal T2-weighted MRI. Neuroimage 2010 2.03
49 Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage 2010 1.94
50 Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage 2007 1.93
51 Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain 2013 1.91
52 The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav 2014 1.90
53 Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond) 2012 1.90
54 Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology 2007 1.88
55 Body mass index and magnetic resonance markers of brain integrity in adults. Ann Neurol 2008 1.88
56 Clinicopathological correlations in corticobasal degeneration. Ann Neurol 2011 1.86
57 Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain 2010 1.86
58 Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging 2005 1.83
59 The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol 2011 1.79
60 Imaging markers for Alzheimer disease: which vs how. Neurology 2013 1.76
61 Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage 2012 1.76
62 Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Neurol 2011 1.75
63 Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol 2013 1.75
64 Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection. Neuroimage 2009 1.71
65 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging 2010 1.70
66 Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals. Neuroimage 2010 1.69
67 Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol Aging 2010 1.69
68 Perioperative cognitive decline in the aging population. Mayo Clin Proc 2011 1.66
69 Selective disruption of the cerebral neocortex in Alzheimer's disease. PLoS One 2010 1.65
70 Voxel-based optimized morphometry (VBM) of gray and white matter in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis. Epilepsia 2006 1.65
71 Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Neuroimage 2009 1.63
72 Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A 2013 1.58
73 Automated MRI-based classification of primary progressive aphasia variants. Neuroimage 2009 1.55
74 Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry. Hum Brain Mapp 2010 1.55
75 Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 T. Neurobiol Aging 2005 1.55
76 Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage 2011 1.54
77 Magnetic resonance imaging of hippocampal subfields in posttraumatic stress disorder. Arch Gen Psychiatry 2010 1.54
78 Comparison of phantom and registration scaling corrections using the ADNI cohort. Neuroimage 2009 1.53
79 Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci 2011 1.51
80 Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. Neuroimage Clin 2013 1.49
81 Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects. Neuroimage 2011 1.48
82 Chronic active heavy drinking and family history of problem drinking modulate regional brain tissue volumes. Psychiatry Res 2005 1.47
83 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Arch Neurol 2004 1.47
84 Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp 2010 1.47
85 Human brain: reliability and reproducibility of pulsed arterial spin-labeling perfusion MR imaging. Radiology 2005 1.45
86 A tensor based morphometry study of longitudinal gray matter contraction in FTD. Neuroimage 2007 1.45
87 Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage 2010 1.45
88 Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch Neurol 2012 1.44
89 Accurate measurement of brain changes in longitudinal MRI scans using tensor-based morphometry. Neuroimage 2011 1.44
90 Breakdown of brain connectivity between normal aging and Alzheimer's disease: a structural k-core network analysis. Brain Connect 2013 1.40
91 Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI. Acta Neuropathol 2011 1.40
92 Detecting sarcasm from paralinguistic cues: anatomic and cognitive correlates in neurodegenerative disease. Neuroimage 2009 1.38
93 CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex 2011 1.38
94 Cerebrovascular disease, β-amyloid, and cognition in aging. Neurobiol Aging 2011 1.37
95 White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiol Aging 2005 1.36
96 Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Mov Disord 2011 1.36
97 Subfield atrophy pattern in temporal lobe epilepsy with and without mesial sclerosis detected by high-resolution MRI at 4 Tesla: preliminary results. Epilepsia 2009 1.33
98 Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease. Neurology 2013 1.32
99 Memory in the aging brain: doubly dissociating the contribution of the hippocampus and entorhinal cortex. Hippocampus 2007 1.32
100 Patterns of altered cortical perfusion and diminished subcortical integrity in posttraumatic stress disorder: an MRI study. Neuroimage 2010 1.30
101 Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid. Alzheimers Dement 2011 1.30
102 Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans. Neurobiol Aging 2010 1.30
103 Neural basis of interpersonal traits in neurodegenerative diseases. Neuropsychologia 2009 1.29
104 Improved perfusion-weighted MRI by a novel double inversion with proximal labeling of both tagged and control acquisitions. Magn Reson Med 2003 1.29
105 Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke 2007 1.27
106 Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity. Proc Natl Acad Sci U S A 2013 1.26
107 ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord 2010 1.26
108 The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci 2013 1.26
109 Automated MRI measures predict progression to Alzheimer's disease. Neurobiol Aging 2010 1.25
110 The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction. JAMA Neurol 2013 1.25
111 AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage 2011 1.24
112 Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers. Brain Imaging Behav 2014 1.23
113 Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain 2011 1.23
114 Arterial spin labeling MRI study of age and gender effects on brain perfusion hemodynamics. Magn Reson Med 2011 1.23
115 Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. Ann Neurol 2013 1.22
116 A non-parametric approach for co-analysis of multi-modal brain imaging data: application to Alzheimer's disease. Neuroimage 2006 1.22
117 Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report. Neurocase 2004 1.21
118 Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment. Ann Neurol 2009 1.21
119 Prevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sample. Brain Behav 2012 1.20
120 Neuropsychological functioning in posttraumatic stress disorder and alcohol abuse. Neuropsychology 2006 1.19
121 Nonlinear time course of brain volume loss in cognitively normal and impaired elders. Neurobiol Aging 2010 1.19
122 Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study. Neurobiol Aging 2010 1.17
123 Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance. J Int Neuropsychol Soc 2005 1.17
124 Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke 2010 1.16
125 Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia. Int J Alzheimers Dis 2011 1.15
126 Clinical and multimodal biomarker correlates of ADNI neuropathological findings. Acta Neuropathol Commun 2013 1.15
127 Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease. Mov Disord 2002 1.15
128 Cardiovascular risk factors, cortisol, and amyloid-β deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement 2012 1.15
129 Non-treatment-seeking heavy drinkers: effects of chronic cigarette smoking on brain structure. Drug Alcohol Depend 2006 1.14
130 Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI. Alzheimer Dis Assoc Disord 2009 1.14
131 Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Biol Psychiatry 2012 1.13
132 SMALL WORLD NETWORK MEASURES PREDICT WHITE MATTER DEGENERATION IN PATIENTS WITH EARLY-STAGE MILD COGNITIVE IMPAIRMENT. Proc IEEE Int Symp Biomed Imaging 2012 1.12
133 Improved diffusion imaging through SNR-enhancing joint reconstruction. Magn Reson Med 2012 1.11
134 Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers Dement 2009 1.11
135 BMI and neuronal integrity in healthy, cognitively normal elderly: a proton magnetic resonance spectroscopy study. Obesity (Silver Spring) 2009 1.11
136 Involvement of the thalamocortical network in TLE with and without mesiotemporal sclerosis. Epilepsia 2009 1.10
137 Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline. Neurobiol Aging 2010 1.10
138 Discovery and Replication of Gene Influences on Brain Structure Using LASSO Regression. Front Neurosci 2012 1.10
139 Dissociations in hippocampal and frontal contributions to episodic memory performance. Neuropsychology 2005 1.09
140 Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiology 2011 1.09
141 Hippocampal volume and retention in Alzheimer's disease. J Int Neuropsychol Soc 2004 1.09
142 Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder. J Rehabil Res Dev 2009 1.08
143 Hippocampal surface mapping of genetic risk factors in AD via sparse learning models. Med Image Comput Comput Assist Interv 2011 1.07
144 Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging. Neuroimage 2010 1.07
145 Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel. PLoS One 2013 1.06
146 Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study. Int J Alzheimers Dis 2011 1.05
147 The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimers Dement 2008 1.05
148 Worldwide Alzheimer's disease neuroimaging initiative. Alzheimers Dement 2012 1.05
149 Magnetic resonance imaging correlates of set shifting. J Int Neuropsychol Soc 2007 1.03
150 Maximizing power to track Alzheimer's disease and MCI progression by LDA-based weighting of longitudinal ventricular surface features. Neuroimage 2013 1.03
151 Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. PLoS One 2013 1.03
152 Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Brain Imaging Behav 2012 1.03
153 Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects. Neuroimage Clin 2013 1.02
154 Locally linear embedding (LLE) for MRI based Alzheimer's disease classification. Neuroimage 2013 1.02
155 Denoising diffusion-weighted magnitude MR images using rank and edge constraints. Magn Reson Med 2014 1.01
156 Are treated alcoholics representative of the entire population with alcohol use disorders? A magnetic resonance study of brain injury. Alcohol 2008 1.01
157 Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta Neuropathol Commun 2014 1.01
158 Voxel-based T2 relaxation rate measurements in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis. Epilepsia 2007 1.01
159 Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults. J Am Geriatr Soc 2012 1.01
160 Patterns of age-related water diffusion changes in human brain by concordance and discordance analysis. Neurobiol Aging 2008 1.01
161 Hippocampal volume differences in Gulf War veterans with current versus lifetime posttraumatic stress disorder symptoms. Biol Psychiatry 2010 1.01
162 Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder. Psychiatry Res 2008 1.01
163 Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networks. Brain Imaging Behav 2012 1.00
164 Chronic cigarette smoking and heavy drinking in human immunodeficiency virus: consequences for neurocognition and brain morphology. Alcohol 2007 1.00
165 N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease. Adv Exp Med Biol 2006 1.00
166 Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data. J Alzheimers Dis 2011 0.99
167 Using automated morphometry to detect associations between ERP latency and structural brain MRI in normal adults. Hum Brain Mapp 2005 0.98
168 Gray matter perfusion correlates with disease severity in ALS. Neurology 2010 0.98
169 Characterization of white matter degeneration in elderly subjects by magnetic resonance diffusion and FLAIR imaging correlation. Neuroimage 2009 0.98
170 Progression of white matter degeneration in amyotrophic lateral sclerosis: A diffusion tensor imaging study. Amyotroph Lateral Scler 2011 0.98
171 Greater regional brain atrophy rate in healthy elderly subjects with a history of cigarette smoking. Alzheimers Dement 2012 0.98
172 Effects of low-level exposure to sarin and cyclosarin during the 1991 Gulf War on brain function and brain structure in US veterans. Neurotoxicology 2010 0.97
173 Deformation-based morphometry reveals brain atrophy in frontotemporal dementia. Arch Neurol 2007 0.97
174 Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke 2012 0.97
175 The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia. Int J Geriatr Psychiatry 2008 0.97
176 Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010. Alzheimers Dement 2011 0.97
177 Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: relationship to conversion to dementia after 3 years. Int J Geriatr Psychiatry 2011 0.96
178 Achieving sufficient spectral bandwidth for volumetric 1H echo-planar spectroscopic imaging at 4 Tesla. Magn Reson Med 2005 0.96
179 Identification of abnormal neuronal metabolism outside the seizure focus in temporal lobe epilepsy. Epilepsia 2004 0.96
180 Expanding ventricles may detect preclinical Alzheimer disease. Neurology 2008 0.95
181 Cortical thinning related to periventricular and deep white matter hyperintensities. Neurobiol Aging 2011 0.95
182 Insomnia severity is associated with a decreased volume of the CA3/dentate gyrus hippocampal subfield. Biol Psychiatry 2010 0.95
183 Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study. Am J Psychiatry 2010 0.95
184 Grey and white matter abnormalities in temporal lobe epilepsy with and without mesial temporal sclerosis. J Neurol 2013 0.95
185 MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements. PLoS One 2013 0.94
186 CSF Apo-E levels associate with cognitive decline and MRI changes. Acta Neuropathol 2014 0.94
187 Gray matter correlates of set-shifting among neurodegenerative disease, mild cognitive impairment, and healthy older adults. J Int Neuropsychol Soc 2010 0.94
188 Attention, learning, and memory in posttraumatic stress disorder. J Trauma Stress 2004 0.94
189 Homocysteine effects on brain volumes mapped in 732 elderly individuals. Neuroreport 2011 0.93
190 Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging. Alzheimer Dis Assoc Disord 2006 0.93
191 Focal hemosiderin deposits and β-amyloid load in the ADNI cohort. Alzheimers Dement 2013 0.91
192 Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain 2014 0.91
193 Four-phase single-capillary stepwise model for kinetics in arterial spin labeling MRI. Magn Reson Med 2005 0.91
194 Measuring longitudinal change in the hippocampal formation from in vivo high-resolution T2-weighted MRI. Neuroimage 2012 0.91
195 PREDICTING TEMPORAL LOBE VOLUME ON MRI FROM GENOTYPES USING L(1)-L(2) REGULARIZED REGRESSION. Proc IEEE Int Symp Biomed Imaging 2012 0.90
196 Atrophy in two attention networks is associated with performance on a Flanker task in neurodegenerative disease. Neuropsychologia 2010 0.90
197 Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N = 1345 young and elderly subjects. Brain Imaging Behav 2013 0.89
198 Patterns of white matter atrophy in frontotemporal lobar degeneration. Arch Neurol 2007 0.89
199 Multisection proton MR spectroscopy for mesial temporal lobe epilepsy. AJNR Am J Neuroradiol 2002 0.89
200 Alzheimer's Disease Neuroimaging Initiative special issue. Neurobiol Aging 2010 0.89
201 Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment. Neurobiol Aging 2013 0.89
202 Influences of lobar gray matter and white matter lesion load on cognition and mood. Psychiatry Res 2010 0.89
203 Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage Clin 2013 0.89
204 Scyllo-inositol in normal aging human brain: 1H magnetic resonance spectroscopy study at 4 Tesla. NMR Biomed 2005 0.89
205 Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRI. Amyotroph Lateral Scler 2011 0.89
206 MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes. J Alzheimers Dis 2013 0.89
207 Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment. Neuroimage Clin 2012 0.88
208 Cortical thickness mediates the effect of β-amyloid on episodic memory. Neurology 2014 0.88
209 In-vivo investigation of the human cingulum bundle using the optimization of MR diffusion spectrum imaging. Eur J Radiol 2009 0.88
210 Improved arterial spin labeling method: applications for measurements of cerebral blood flow in human brain at high magnetic field MRI. Med Phys 2007 0.88
211 Right and left medial orbitofrontal volumes show an opposite relationship to agreeableness in FTD. Dement Geriatr Cogn Disord 2004 0.87
212 Forgetting in dementia with and without subcortical lacunes. Clin Neuropsychol 2004 0.87
213 Patterns of reduced cortical thickness in late-life depression and relationship to psychotherapeutic response. Am J Geriatr Psychiatry 2013 0.87
214 Spontaneous brain activity in combat related PTSD. Neurosci Lett 2013 0.87
215 Rule violation errors are associated with right lateral prefrontal cortex atrophy in neurodegenerative disease. J Int Neuropsychol Soc 2009 0.87
216 Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition. Neurology 2014 0.86
217 Military risk factors for cognitive decline, dementia and Alzheimer's disease. Curr Alzheimer Res 2013 0.86
218 Reduced extrahippocampal NAA in mesial temporal lobe epilepsy. Epilepsia 2002 0.86
219 Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly. Neuroreport 2013 0.86
220 Quantitative magnetic resonance imaging differences between Alzheimer disease with and without subcortical lacunes. Alzheimer Dis Assoc Disord 2002 0.86
221 ERP evidence of impaired central nervous system function in virally suppressed HIV patients on antiretroviral therapy. Clin Neurophysiol 2004 0.86
222 Effects of low-level sarin and cyclosarin exposure and Gulf War Illness on brain structure and function: a study at 4T. Neurotoxicology 2011 0.85
223 Cortisol levels are positively correlated with hippocampal N-acetylaspartate. Biol Psychiatry 2003 0.85
224 Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimers Dement 2011 0.85
225 Different structural correlates for verbal memory impairment in temporal lobe epilepsy with and without mesial temporal lobe sclerosis. Hum Brain Mapp 2011 0.85
226 Widespread extrahippocampal NAA/(Cr+Cho) abnormalities in TLE with and without mesial temporal sclerosis. J Neurol 2010 0.85
227 A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations. Hum Brain Mapp 2013 0.85
228 Mapping creatinine- and cystatin C-related white matter brain deficits in the elderly. Neurobiol Aging 2012 0.85
229 Regional myo-inositol concentration in mild cognitive impairment Using 1H magnetic resonance spectroscopic imaging. Alzheimer Dis Assoc Disord 2009 0.85
230 Evidence of neuronal injury outside the medial temporal lobe in temporal lobe epilepsy: N-acetylaspartate concentration reductions detected with multisection proton MR spectroscopic imaging--initial experience. Radiology 2003 0.85
231 Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with Pick's disease. J Mol Neurosci 2011 0.83
232 Abnormal contingent negative variation in HIV patients receiving antiretroviral therapy. Neuroreport 2003 0.83
233 Abnormal CNV in chronic heavy drinkers. Clin Neurophysiol 2003 0.83
234 MRI patterns of atrophy and hypoperfusion associations across brain regions in frontotemporal dementia. Neuroimage 2011 0.83
235 Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. Eur J Nucl Med Mol Imaging 2012 0.83
236 Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. J Neurosci Methods 2010 0.82
237 Concordance and discordance between brain perfusion and atrophy in frontotemporal dementia. Brain Imaging Behav 2010 0.82
238 MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study population. Alzheimer Dis Assoc Disord 2009 0.82
239 The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment. Am J Geriatr Psychiatry 2013 0.82
240 K-Bayes reconstruction for perfusion MRI. I: concepts and application. J Digit Imaging 2009 0.82
241 Spectroscopic metabolic abnormalities in mTLE with and without MRI evidence for mesial temporal sclerosis using hippocampal short-TE MRSI. Epilepsia 2003 0.82
242 Neuroimaging predictors of brain amyloidosis in mild cognitive impairment. Ann Neurol 2013 0.81
243 Mapping Dynamic Changes in Ventricular Volume onto Baseline Cortical Surfaces in Normal Aging, MCI, and Alzheimer's Disease. Multimodal Brain Image Anal (2013) 2013 0.81
244 Magnetic resonance spectroscopic imaging reconstruction with deformable shape-intensity models. Magn Reson Med 2003 0.81
245 Identification of the epileptogenic lobe in neocortical epilepsy with proton MR spectroscopic imaging. Epilepsia 2004 0.81
246 Changes in brain anatomy during the course of posttraumatic stress disorder. Psychiatry Res 2011 0.80
247 Automatic Prediction of Conversion from Mild Cognitive Impairment to Probable Alzheimer's Disease using Structural Magnetic Resonance Imaging. AMIA Annu Symp Proc 2010 0.80
248 Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort. Dement Geriatr Cogn Disord 2014 0.79
249 The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors. Neuroimage 2011 0.79
250 Different associations of white matter lesions with depression and cognition. BMC Neurol 2012 0.79
251 Neuroprotective Effects of Lithium in Human Brain? Food for Thought. Curr Alzheimer Res 2016 0.79
252 Pilot expertise and hippocampal size: associations with longitudinal flight simulator performance. Aviat Space Environ Med 2012 0.79
253 Diffusion anisotropy indexes are sensitive to selecting the EPI readout-encoding bandwidth at high-field MRI. Magn Reson Imaging 2008 0.79
254 The role of carotid intima-media thickness in predicting longitudinal cognitive function in an older adult cohort. Cerebrovasc Dis 2014 0.79
255 Longitudinal effects of PTSD on memory functioning. J Int Neuropsychol Soc 2009 0.78
256 AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trials. Alzheimers Dement 2011 0.78
257 Sensitive and fast T1 mapping based on two inversion recovery images and a reference image. Med Phys 2005 0.77
258 Differential effects of ischemic vascular disease and Alzheimer's disease on brain atrophy and cognition. J Cereb Blood Flow Metab 2016 0.77
259 Improved pseudo-continuous arterial spin labeling for mapping brain perfusion. J Magn Reson Imaging 2010 0.77
260 Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment. Neurobiol Aging 2013 0.77
261 Voxel-wise co-analysis of macro- and microstructural brain alteration in mild cognitive impairment and Alzheimer's disease using anatomical and diffusion MRI. J Neuroimaging 2013 0.76
262 Individual subject classification of mixed dementia from pure subcortical vascular dementia based on subcortical shape analysis. PLoS One 2013 0.76
263 Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum. Neurodegener Dis 2015 0.75
264 Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. PLoS One 2016 0.75
265 Magnetic resonance imaging of dementia. Top Magn Reson Imaging 2005 0.75